SELLAS Life Sciences Group, Inc. — Director's Dealing 2014

Jul 30, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Galena Biopharma, Inc. (GALE)
CIK: 0001390478
Period of Report: 2014-07-28

Reporting Person: Kivinski Margaret (VP and General Counsel)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-07-28	Stock Option (right to buy)	$2.92	A	200000	Acquired	2024-07-28	Common Stock (200000)	Direct

Footnotes

F1: Granted pursuant to the Issuer's Amended and Restated 2007 Incentive Plan.

F2: The option will vest in 16 equal quarterly installments of 12,500 shares over four years beginning on the first quarterly anniversary of the grant date (i.e., July 28, 2014), provided, in each case, that Reporting Person remains in the continuous employ of the Issuer through such quarterly anniversary date.